Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10833717 | Molecular Genetics and Metabolism | 2014 | 7 Pages |
Abstract
Barth syndrome is caused by mutations in the TAZ (tafazzin) gene on human chromosome Xq28. The human tafazzin gene produces four major mRNA splice variants; two of which have been shown to be functional (TAZ lacking exon 5 and full-length) in complementation studies with yeast and Drosophila. This study characterizes the multiple alternative splice variants of TAZ mRNA and their proportions in blood samples from a cohort of individuals with Barth syndrome (BTHS). Because it has been reported that collection and processing methods can affect the expression of various genes, we tested and chose a stabilizing medium for collecting, shipping and processing of the blood samples of these individuals. In both healthy controls and in BTHS individuals, we found a greater variety of alternatively spliced forms than previously described, with a sizeable proportion of minor splice variants besides the four dominant isoforms. Individuals with certain exonic and intronic splice mutations produce additional mutant mRNAs that could be translated into two or more proteins with different amino acid substitutions in a single individual. A fraction of the minor splice variants is predicted to be non-productive.
Keywords
XCINHLBITAZLVNCPhytohemagglutininDCMPHAFAMMLCLBTHSUTREDTAEthylenediaminetetraacetic acidCapillary electrophoresisEBVTafazzinAlternative splicingreverse transcriptionBarth syndromefull lengthLeft ventricular noncompactionX-chromosome inactivationNational Heart, Lung, and Blood Instituteuntranslated regionMonolysocardiolipinpolymerase chain reactionPCREpstein–Barr virusCardiolipinDilated cardiomyopathyhigh performance liquid chromatographyHPLC
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Susan M. Kirwin, Athena Manolakos, Sarah Swain Barnett, Iris L. Gonzalez,